ChartMill assigns a Buy % Consensus number of 86% to CRBU. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-04-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | B of A Securities | Maintains | Buy -> Buy |
| 2024-11-26 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-16 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-11-08 | Cantor Fitzgerald | Initiate | Neutral |
| 2023-07-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-14 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-07-11 | Truist Securities | Initiate | Buy |
| 2023-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-14 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-10 | Oppenheimer | Maintains | Outperform |
| 2023-03-10 | RBC Capital | Reiterate | Outperform |
| 2022-08-29 | Citigroup | Maintains | Buy |
| 2022-08-18 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-10 | RBC Capital | Maintains | Outperform |
| 2022-05-13 | Citigroup | Maintains | Buy |
| 2022-05-12 | SVB Leerink | Maintains | Outperform |
| 2022-05-10 | SVB Leerink | Maintains | Outperform |
14 analysts have analysed CRBU and the average price target is 11.09 USD. This implies a price increase of 670.31% is expected in the next year compared to the current price of 1.44.
The consensus rating for CARIBOU BIOSCIENCES INC (CRBU) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CARIBOU BIOSCIENCES INC (CRBU) is 14.